Recently presented promising XMT-1536 Phase 1 dose escalation data and established maximum tolerated dose, subsequently raising $65M of gross proceeds […]
MANSFIELD, Mass., May 08, 2020 (GLOBE NEWSWIRE) — inTEST Corporation (NYSE American: INTT), a global supplier of precision-engineered solutions for […]